Furthermore, the upregulation of β-TrCP and disruption of the oncogenic loops of the STAT3–β-catenin–NF-κB signaling pathway by CIB-6 were found to prevent HCC tumorigenesis in vitro and in vivo (Figure 7E). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.